3SBio (TRSBF) Expected to Announce Quarterly Earnings on Monday

3SBio (OTCMKTS:TRSBF) will likely be releasing its results before the market opens on Monday, March 30th. Analysts expect 3SBio to post earnings of $0.5160 per share and revenue of $1.9761 billion for the quarter.

3SBio Price Performance

Shares of OTCMKTS TRSBF opened at $2.61 on Friday. The business has a fifty day moving average price of $2.80 and a two-hundred day moving average price of $3.36. 3SBio has a fifty-two week low of $2.22 and a fifty-two week high of $4.74.

3SBio Company Profile

3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.

The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.